New Swiss Vaccine Research Institute to Use EPFL's Omics Technologies | GenomeWeb
NEW YORK (GenomeWeb News) - The Swiss Institute for Vaccine Research, scheduled to open today, will use genomics, proteomics, molecular screening, and imaging technologies provided by the Ecole Polytechnique Fédérale de Lausanne.
 
EPFL will use these technologies to study virology, microbiology, and vectorology and develop new high-flow and automated immunology tests.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.